...
aim-img

AIM ImmunoTech Inc, Common Stock

AIM

ASQ

$0.19

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.19M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
343.25K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.36
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.16 L
$0.62 H
$0.19

About AIM ImmunoTech Inc, Common Stock

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAIMSectorS&P500
1-Week Return-13.24%-2.12%-3%
1-Month Return-5%-3.42%-0.73%
3-Month Return-28.89%-11.13%2.87%
6-Month Return-51.72%-5.74%7.17%
1-Year Return-61.22%3.97%25.31%
3-Year Return-83.76%1.05%28.38%
5-Year Return-60.42%34.37%81.89%
10-Year Return-99.85%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue140.00K163.00K135.00K141.00K202.00K[{"date":"2019-12-31","value":69.31,"profit":true},{"date":"2020-12-31","value":80.69,"profit":true},{"date":"2021-12-31","value":66.83,"profit":true},{"date":"2022-12-31","value":69.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue893.00K806.00K850.00K19.92M42.00K[{"date":"2019-12-31","value":4.48,"profit":true},{"date":"2020-12-31","value":4.05,"profit":true},{"date":"2021-12-31","value":4.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.21,"profit":true}]
Gross Profit(753.00K)(643.00K)(715.00K)(19.78M)160.00K[{"date":"2019-12-31","value":-470.63,"profit":false},{"date":"2020-12-31","value":-401.88,"profit":false},{"date":"2021-12-31","value":-446.88,"profit":false},{"date":"2022-12-31","value":-12363.75,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(537.86%)(394.48%)(529.63%)(14029.79%)79.21%[{"date":"2019-12-31","value":-679.04,"profit":false},{"date":"2020-12-31","value":-498.03,"profit":false},{"date":"2021-12-31","value":-668.66,"profit":false},{"date":"2022-12-31","value":-17712.61,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses11.69M14.37M16.34M20.06M32.08M[{"date":"2019-12-31","value":36.44,"profit":true},{"date":"2020-12-31","value":44.81,"profit":true},{"date":"2021-12-31","value":50.95,"profit":true},{"date":"2022-12-31","value":62.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(12.44M)(15.15M)(18.84M)(19.92M)(31.92M)[{"date":"2019-12-31","value":-1244300000,"profit":false},{"date":"2020-12-31","value":-1515200000,"profit":false},{"date":"2021-12-31","value":-1883800000,"profit":false},{"date":"2022-12-31","value":-1992300000,"profit":false},{"date":"2023-12-31","value":-3191600000,"profit":false}]
Total Non-Operating Income/Expense2.57M80.00K(356.00K)1.11M-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":3.11,"profit":true},{"date":"2021-12-31","value":-13.84,"profit":false},{"date":"2022-12-31","value":43.04,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(9.53M)(14.40M)(19.13M)(19.45M)(28.96M)[{"date":"2019-12-31","value":-953300000,"profit":false},{"date":"2020-12-31","value":-1440000000,"profit":false},{"date":"2021-12-31","value":-1912700000,"profit":false},{"date":"2022-12-31","value":-1944500000,"profit":false},{"date":"2023-12-31","value":-2896200000,"profit":false}]
Income Taxes1.29M1.86M2.39M1.64M-[{"date":"2019-12-31","value":54.19,"profit":true},{"date":"2020-12-31","value":77.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.78,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(10.83M)(16.26M)(21.51M)(21.09M)-[{"date":"2019-12-31","value":-1082600000,"profit":false},{"date":"2020-12-31","value":-1625800000,"profit":false},{"date":"2021-12-31","value":-2151300000,"profit":false},{"date":"2022-12-31","value":-2108600000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(9.40M)(14.40M)(19.13M)(19.45M)-[{"date":"2019-12-31","value":-940400000,"profit":false},{"date":"2020-12-31","value":-1440000000,"profit":false},{"date":"2021-12-31","value":-1912700000,"profit":false},{"date":"2022-12-31","value":-1944500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(10.83M)(16.26M)(21.51M)(21.09M)(28.96M)[{"date":"2019-12-31","value":-1082600000,"profit":false},{"date":"2020-12-31","value":-1625800000,"profit":false},{"date":"2021-12-31","value":-2151300000,"profit":false},{"date":"2022-12-31","value":-2108600000,"profit":false},{"date":"2023-12-31","value":-2896200000,"profit":false}]
EPS (Diluted)(10.08)(1.04)-(1.48)(1.05)[{"date":"2019-12-31","value":-1008,"profit":false},{"date":"2020-12-31","value":-103.77,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-148,"profit":false},{"date":"2023-12-31","value":-105.22,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AIM
Cash Ratio 0.71
Current Ratio 0.75

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AIM
ROA (LTM) -80.04%
ROE (LTM) -154.79%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AIM
Debt Ratio Lower is generally better. Negative is bad. 0.79
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.21

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AIM
Trailing PE NM
Forward PE NM
P/S (TTM) 60.29
P/B 4.16
Price/FCF NM
EV/R 43.77
EV/Ebitda 0.49

FAQs

What is AIM ImmunoTech Inc share price today?

AIM ImmunoTech Inc (AIM) share price today is $0.19

Can Indians buy AIM ImmunoTech Inc shares?

Yes, Indians can buy shares of AIM ImmunoTech Inc (AIM) on Vested. To buy AIM ImmunoTech Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AIM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AIM ImmunoTech Inc be purchased?

Yes, you can purchase fractional shares of AIM ImmunoTech Inc (AIM) via the Vested app. You can start investing in AIM ImmunoTech Inc (AIM) with a minimum investment of $1.

How to invest in AIM ImmunoTech Inc shares from India?

You can invest in shares of AIM ImmunoTech Inc (AIM) via Vested in three simple steps:

  • Click on Sign Up or Invest in AIM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AIM ImmunoTech Inc shares
What is AIM ImmunoTech Inc 52-week high and low stock price?

The 52-week high price of AIM ImmunoTech Inc (AIM) is $0.62. The 52-week low price of AIM ImmunoTech Inc (AIM) is $0.16.

What is AIM ImmunoTech Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AIM ImmunoTech Inc (AIM) is

What is AIM ImmunoTech Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AIM ImmunoTech Inc (AIM) is 4.16

What is AIM ImmunoTech Inc dividend yield?

The dividend yield of AIM ImmunoTech Inc (AIM) is 0.00%

What is the Market Cap of AIM ImmunoTech Inc?

The market capitalization of AIM ImmunoTech Inc (AIM) is $12.19M

What is AIM ImmunoTech Inc’s stock symbol?

The stock symbol (or ticker) of AIM ImmunoTech Inc is AIM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top